Trial Details
TERMINATEDBasic Information
| Clinical ID | c4434 |
|---|---|
| Identifier | NCT00537316 |
| Trial Title | Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | BIOLOGICAL: Infliximab (IFX)|DRUG: Azathioprine (AZA)|DRUG: Placebo to Azathioprine|DRUG: Placebo infusion |
Participant Information
| Sponsor | Merck Sharp & Dohme LLC |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2007-07 |
|---|---|
| Primary Completion Date | 2010-02 |
| Completion Date | 2010-02 |